君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

已收盘 09-02 16:08:07

17.940

+0.180

+1.01%

最高18.130	最低17.500	成交量186.52万
今开17.760	昨收17.760	日振幅3.55%
总市值184.24亿	流通市值46.64亿	总股本10.27亿
成交额3,330万	换手率0.72%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":17.94,"timestamp":1788336487003,"preClose":17.76,"halted":0,"volume":1865200,"delay":0,"changeRate":0.010135135135135118,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"已收盘","change":0.18,"latestTime":"09-02 16:08:07","open":17.76,"high":18.13,"low":17.5,"amount":33304820,"amplitude":0.035473,"askPrice":17.94,"askSize":2800,"bidPrice":17.88,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.451,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":5,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":17.76,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.461853,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物-U","latestPrice":33.08,"timestamp":1788332400000,"preClose":33.27,"halted":0,"volume":10538100,"delay":0,"premium":"-53.53"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2664892928","title":"智通AH统计|9月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892928","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664892928?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:15","pubTimestamp":1788336906,"startTime":"0","endTime":"0","summary":"东北电气0.2432.251011.11%-9.29%浙江世宝4.03517.05406.07%50.65%弘业期货2.2508.16334.22%23.89%中石化油服0.6602.23304.55%-5.17%晨鸣纸业0.5951.92286.55%29.01%复旦张江2.5158.06283.70%5.24%凯盛新能2.2657.21281.46%28.57%南京熊猫电子股份3.27010266.36%21.77%安德利果汁21.74066.08264.08%-10.48%京城机电股份2.8208.51261.35%26.19%. 宁德时代564.500360.28-23.55%2.52%招商银行51.75040.87-5.41%-0.95%药明康德193.700155.99-3.54%0.63%兆易创新472.200388.86-1.36%-0.23%中际旭创996.000830.33-0.14%-1.53%潍柴动力30.30026.293.93%1.04%美的集团99.95086.984.23%-0.97%立讯精密63.60057.087.50%-6.73%交通银行7.9307.4312.23%-1.61%紫金矿业35.80033.7312.85%-1.18%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00668","83188","83130","02899","02359","00187","03678","00991","02827","06869","03143","03308","03750","03968","03130","IE0034224299.USD","00042","01033","03986","00981","159982","06613","LU0039217434.USD","00553","82846","00300","03759","06185","02846","03188","01108","00568","02701","02218","06826","02475","01055","LU0890818403.SGD","EWH","01057","399300","03296","07233","01812","01877","02338","06821","01349","03328"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073923","title":"智通AH统计|8月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663073923?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:15","pubTimestamp":1788164105,"startTime":"0","endTime":"0","summary":"东北电气0.2422.251015.70%2.16%浙江世宝3.96016.58401.52%51.14%弘业期货2.2407.91322.77%14.23%中石化油服0.6602.29315.15%6.17%复旦张江2.5208.09284.52%6.86%晨鸣纸业0.6101.91275.41%18.37%凯盛新能2.2957.18274.73%24.65%安德利果汁22.20067.75265.54%-13.04%南京熊猫电子股份3.3159.73251.43%9.64%京城机电股份2.8508.29248.42%16.04%. 康希诺生物29.50085.36246.58%74.87%浙江世宝3.96016.58401.52%51.14%山东墨龙4.7008.45115.32%30.05%凯盛新能2.2957.18274.73%24.65%晨鸣纸业0.6101.91275.41%18.37%上海电气2.9106.58170.79%17.02%京城机电股份2.8508.29248.42%16.04%沃尔核材10.07017.12103.67%14.52%中国国航3.7705.9488.59%14.33%丽珠医药19.88026.4759.51%14.26%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07233","06869","01812","399300","01349","01513","00991","03143","03200","02846","03130","06185","159982","01057","03268","03986","LU0327786744.USD","00568","06690","82846","01877","03308","EWH","00317","01033","03328","02475","02727","LU0348816934.USD","00753","00553","83130","03678","02359","01108","09981","02691","03750","03188","03968","02827","83188","00300","00042","00187","02218","03296","00981","02338"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663022166","title":"破发股君实生物股东拟减持 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663022166","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663022166?lang=zh_cn&edition=full","pubTime":"2026-08-31 13:54","pubTimestamp":1788155643,"startTime":"0","endTime":"0","summary":"中国经济网北京8月31日讯 君实生物 昨日晚间披露《关于股东减持股份计划的公告》。　　截至公告披露日，上海檀英持有君实生物股份38,925,626股，股份性质为A股，占公司总股本的3.7914%。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金金额合计86.12亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260831/32354490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1515","BK1583","IPOS","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663282950","title":"君实生物(01877.HK)：上海檀英拟减持不超过2%A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2663282950","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663282950?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:15","pubTimestamp":1788135349,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["83130","02827","BK1161","03130","02846","82846","BK1515","03188","83188","07233","BK1147","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106911930","title":"君实生物披露股东减持计划 上海檀英拟三个月内减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1106911930","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106911930?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:01","pubTimestamp":1788134461,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司8月31日公告称，持股3.7914%的股东上海檀英投资合伙企业拟自2026年9月21日至2026年12月20日期间，合计减持公司股份不超过20,533,796股，减持比例不超过公司总股本的2%。公告显示，截至8月31日，上海檀英持有君实生物38,925,626股A股，为公司IPO前取得并已于2021年7月15日起解除限售的股份。此次减持不会导致公司控制权变更。君实生物承诺将按照相关法规及时披露减持进展，提醒投资者关注市场风险。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663042597","title":"股市必读：君实生物新发布《君实生物关于股东减持股份计划的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663042597","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663042597?lang=zh_cn&edition=full","pubTime":"2026-08-31 01:13","pubTimestamp":1788109987,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，君实生物报收于33.56元，下跌5.65%，换手率3.24%，成交量24.84万手，成交额8.53亿元。当日关注点交易信息汇总：8月28日主力资金净流出7280.3万元，占总成交额8.54%。机构调研要点：公司于2026年8月26日召开业绩说明会。公司公告汇总：股东上海檀英拟减持不超过20,533,796股，占总股本比例不超过2%，减持期间为2026年9月21日至12月20日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","BK1583","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049864","title":"君实生物：上海檀英拟减持不超2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049864","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049864?lang=zh_cn&edition=full","pubTime":"2026-08-30 15:45","pubTimestamp":1788075922,"startTime":"0","endTime":"0","summary":"南财智讯8月30日电，君实生物公告，公司股东上海檀英投资合伙企业（有限合伙）因基金期限与流动性资金安排原因，计划通过集中竞价交易和大宗交易方式合计减持公司股份不超过2053.38万股，减持比例不超过公司总股本的2%。减持期间为2026年9月21日至2026年12月20日，减持价格按市场价格确定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608303859390920.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608303859390920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010362","title":"每周股票复盘：君实生物（688180）Q2归母净利润同比增123.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010362","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010362?lang=zh_cn&edition=full","pubTime":"2026-08-30 01:44","pubTimestamp":1788025451,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，君实生物报收于33.56元，较上周的37.42元下跌10.32%。本周关注点来自业绩披露要点：2026年第二季度归母净利润4222.71万元，同比上升123.75%。股本股东变化截至2026年6月30日，公司股东户数为3.77万户，较3月31日减少465户，减幅1.22%。户均持股数量由2.01万股增至2.03万股，户均持股市值为68.74万元。负债率为56.68%，毛利率为83.18%，研发投入占营业收入比例为37.96%。公司对截至2026年6月30日的资产进行减值测试，2026年半年度共计计提资产减值准备13,561.59万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662912020","title":"君实生物：8月26日召开业绩说明会，花旗、华西证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2662912020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662912020?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:39","pubTimestamp":1787927972,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年8月28日君实生物发布公告称公司于2026年8月26日召开业绩说明会，花旗、华西证券、华源证券、开源证券、申万宏源证券、天风证券、浙商证券、中金公司、中泰证券、中邮证券、投资者、东北证券、东方财富证券、东吴证券、广发证券、国海证券、国金证券、国联民生证券、国泰海通证券参与。该股最近90天内共有4家机构给出评级，买入评级4家。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800055423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","002926","BK1583","01877","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036773","title":"君实生物（688180）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036773","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662036773?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:18","pubTimestamp":1787869085,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期君实生物发布2026年中报。截至本报告期末，公司营业总收入16.96亿元，同比上升45.18%，归母净利润2166.3万元，同比上升105.25%。本报告期君实生物盈利能力上升，毛利率同比增幅3.9%，净利率同比增幅93.96%。本文数据来源于君实生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662366960","title":"股市必读：君实生物中报 - 第二季度单季净利润同比增长123.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662366960","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662366960?lang=zh_cn&edition=full","pubTime":"2026-08-28 05:58","pubTimestamp":1787867895,"startTime":"0","endTime":"0","summary":"2026年上半年归母净利润2166.3万元，同比上升105.25%；第二季度单季度归母净利润4222.71万元，同比上升123.75%。第二季度单季度主营收入9.7亿元，同比上升45.24%；单季度归母净利润4222.71万元，同比上升123.75%；单季度扣非净利润-5982.93万元，同比上升74.96%；负债率56.68%，毛利率83.18%，财务费用7421.79万元，投资收益1.08亿元。公司公告汇总君实生物2026年半年度报告摘要报告期末总资产1,420,156.37万元，较上年度末增长14.69%；归属于上市公司股东的净资产594,373.73万元，较上年度末下降1.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800009984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2662223701","title":"君实生物（688180）披露2026年半年度报告，8月27日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662223701","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662223701?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:27","pubTimestamp":1787830036,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，君实生物报收于35.57元，较前一交易日上涨0.25%，最新总市值为365.19亿元。君实生物于近日披露《2026年半年度报告》。本报告期营业收入为169,621.09万元，同比增长45.18%；利润总额为-3,338.02万元，上年同期为-48,521.16万元；归属于上市公司股东的净利润为2,166.30万元，上年同期为-41,269.56万元；归属于上市公司股东的扣除非经常性损益的净利润为-20,343.85万元，上年同期为-47,842.82万元。研发投入占营业收入的比例为37.96%，上年同期为60.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1161","BK1583","01877","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662727498","title":"国金证券：给予君实生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662727498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662727498?lang=zh_cn&edition=full","pubTime":"2026-08-27 12:23","pubTimestamp":1787804597,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕近期对君实生物进行研究并发布了研究报告《特瑞普利放量提速，创新管线或迎关键催化》，给予君实生物买入评级。特瑞普利单抗已在中国内地获批13项适应症，其中12项纳入国家医保目录。考虑到公司充裕的现金储备为管线推进提供坚实保障，维持\"买入\"评级。最新盈利预测明细如下：该股最近90天内共有2家机构给出评级，买入评级2家。本文数据来源于国金证券股份有限公司，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700028278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662721309","title":"港股异动 | 君实生物(01877.HK)涨超4% 上半年股东应占溢利2550.1万元 拓益®国内销售收入同比增加约36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662721309","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662721309?lang=zh_cn&edition=full","pubTime":"2026-08-27 09:42","pubTimestamp":1787794949,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01877","BK1583","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729977","title":"【券商聚焦】国投证券：创新药有望开启新一轮高景气周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729977","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662729977?lang=zh_cn&edition=full","pubTime":"2026-08-27 09:29","pubTimestamp":1787794154,"startTime":"0","endTime":"0","summary":"金吾财讯 | 国投证券研究指，医药景气新周期背景下，国内创新药产业链加速崛起。近年国家多举措全链条支持创新药发展，叠加国内得天独厚的人才储备和研发效率等多维优势，国内创新药持续加速崛起且逐步具备全球竞争力。与此同时，海外MNC陆续面临专利悬崖困境，对外采购和扩充创新管线需求与日俱增，国内创新药企顺势而为，以海外授权BD等形式实现创新出海，创新药有望开启新一轮高景气周期。风险提示：产品研发及审批速度低于预期；产品降价超预期风险；海外BD授权不及预期风险；计算及假设不及预期风险。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmQzNzBkZGZmOTg1MzM5MTQzMTA0Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989630","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","159992","01177","LU1807302812.USD","LU0463099449.HKD","IE0008369823.USD","LU0417516738.SGD","IBBQ","LU0307460666.USD","02142","LU1969619763.USD","LU2242644610.SGD","LU0348825331.USD","IE00BPRC5H50.USD","02269","161027","LU1226287875.USD","LU0455707207.USD","01801","MEDX","06160","SG9999002562.SGD","09688","LU0039217434.USD","LU1770034418.SGD","LNGR","KURE","SG9999004220.SGD","KCE","01093","LU0314109678.HKD","LU0634319403.HKD","LU0140636845.USD","LU0348783233.USD","BK1589","02616","LU0516423091.SGD","LU0880133367.SGD","09926","LU0359201612.USD","06978","LU0051755006.USD","06185","LU0348767384.USD","LU1813983027.USD","LU1794554557.SGD","09995","01877","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662746352","title":"股市必读：君实生物新发布《君实生物2026年度“提质增效重回报”行动方案的半年度评估报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662746352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662746352?lang=zh_cn&edition=full","pubTime":"2026-08-27 01:07","pubTimestamp":1787764034,"startTime":"0","endTime":"0","summary":"公司公告汇总：君实生物2026年度“提质增效重回报”行动方案半年度评估报告显示，公司实现营收16.96亿元，同比增长45.18%，特瑞普利单抗国内销售收入达12.99亿元。报告期内，公司5款产品处于III期临床，2款进入NDA受理阶段；生产体系持续优化，保障国内外稳定供应；实现营收16.96亿元，同比增长45.18%，特瑞普利单抗国内销售收入达12.99亿元；海外市场拓展至超50个国家和地区，与多家国际企业达成合作；累计获授权专利202件；实际控制人增持股份超325万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700003325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","01877","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662453607","title":"君实生物(688180.SH)发布半年度业绩，归母净利润2166.3万元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2662453607","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662453607?lang=zh_cn&edition=full","pubTime":"2026-08-27 00:17","pubTimestamp":1787761055,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物 披露2026年半年度报告，报告期公司实现营业收入16.96亿元，同比增长45.18%;归属于上市公司股东的净利润2166.3万元，同比扭亏为盈;归属于上市公司股东的扣除非经常性损益的净利润亏损2.03亿元，同比收窄;基本每股收益0.02元。报告期内，公司在创新药物的发现、研发、生产和商业化等方面皆有源头创新性、突破性进展，现金流情况良好，公司核心管理层及研发团队稳定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271798","title":"君实生物上半年扭亏为盈 核心抗癌药国内收入近13亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271798","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662271798?lang=zh_cn&edition=full","pubTime":"2026-08-26 21:54","pubTimestamp":1787752440,"startTime":"0","endTime":"0","summary":"靠一款核心肿瘤药，君实生物再次实现扭亏为盈。8月26日晚间，上海君实生物医药科技股份有限公司（君实生物，688180.SH；1877.HK）发布2026年中期业绩。上半年实现营业收入16.96亿元，同比增长约45.18%，其中药品销售收入达到14.07亿元，同比增长33%。同期，归母净利润为0.22亿元，同比扭亏为盈。wind显示，君实生物上次扭亏为盈发生在2021年上半年。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608263855129318.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608263855129318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01877","BK1515","BK1161","BK1583","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110813676","title":"君实生物(01877)公布董事会决议：20.19亿元募资余额在手，拟1,500万美元转让海外子公司控股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1110813676","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110813676?lang=zh_cn&edition=full","pubTime":"2026-08-26 20:53","pubTimestamp":1787748795,"startTime":"0","endTime":"0","summary":"2026年8月26日，上海君实生物医药科技股份有限公司召开第四届董事会第二十二次会议并披露多项决议及半年度资金使用情况。– 君实生物2022年度向特定对象发行A股募资净额374,480.28万元，报告期新增使用20,040.61万元，累计已使用159,291.73万元。君实生物表示，以上交易及资金安排尚需完成相关审批及交割条件，存在一定不确定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157981247","title":"君实生物(01877)披露2026年上半年业绩：营业收入同比增45.18% 研发投入6.44亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157981247","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157981247?lang=zh_cn&edition=full","pubTime":"2026-08-26 20:26","pubTimestamp":1787747219,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司8月26日发布2026年半年度报告。报告期内，公司实现营业收入16.96亿元，同比增长45.18%。归属于上市公司股东的净利润2,166.30万元，较上年同期的亏损4.13亿元明显改善。截至6月30日，公司总资产142.02亿元，较上年度末增长14.69%；归属于上市公司股东的净资产59.44亿元；资产负债率56.68%，较上年度末上升5.59个百分点。研发投入方面，公司上半年投入6.44亿元，占营业收入的37.96%，其中临床研究及技术服务费3.61亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0467},{"period":"1month","weight":-0.0274},{"period":"3month","weight":-0.0193},{"period":"6month","weight":-0.0384},{"period":"1year","weight":-0.4615},{"period":"ytd","weight":-0.1678}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0118},{"period":"6month","weight":0.0003},{"period":"1year","weight":-0.0112},{"period":"ytd","weight":-0.0117}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.105939},{"month":5,"riseRate":0.375,"avgChangeRate":-0.021039},{"month":6,"riseRate":0.375,"avgChangeRate":-0.04216},{"month":7,"riseRate":0.625,"avgChangeRate":-0.000677},{"month":8,"riseRate":0.125,"avgChangeRate":-0.039004},{"month":9,"riseRate":0.25,"avgChangeRate":-0.022821},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}